Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 48 full-time employees. The firm designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The firm`s product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.
Website: sensushealthcare.com



Growth: Bad revenue growth rate 0.0%, there is slowdown compared to average historical growth rates 68.0%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +52.0%. On average the margin is improving unsteadily. Gross margin is high, +62.3%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -3.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 75.4% higher than minimum and 78.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 6.5x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: SRTS
Share price, USD:  (-3.5%)3.28
year average price 3.04  


year start price 4.74 2023-04-27

min close price 1.87 2023-11-13

max close price 4.91 2024-02-20

current price 3.28 2024-04-25
Common stocks: 16 245 343

Dividend Yield:  0.0%
FCF Yield LTM: -3.8%
EV / LTM EBITDA: 2.4x
EV / EBITDA annualized: 1.6x
Last revenue growth (y/y):  0.0%
Last growth of EBITDA (y/y):  25.0%
Historical revenue growth:  68.0%
Historical growth of EBITDA:  ---
EV / Sales: 1.3x
Margin (EBITDA LTM / Revenue): 52.0%
Fundamental value created in LTM:
Market Cap ($m): 53
Net Debt ($m): -22
EV (Enterprise Value): 31
Price to Book: 1.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-02-08Seeking Alpha

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript

2024-02-08Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates

2024-01-30GlobeNewsWire

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

2023-11-09Seeking Alpha

Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript

2023-08-06Seeking Alpha

Sensus Healthcare, Inc (SRTS) Q2 2023 Earnings Call Transcript

2023-08-03Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

2023-07-11Zacks Investment Research

Sensus Healthcare (SRTS) Expands Global Base With New Pact

2023-05-03Zacks Investment Research

Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Misses Revenue Estimates

2023-04-25GlobeNewsWire

Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-15 2023-11-13 2023-08-11 2023-05-12 2023-03-23 2022-11-10
acceptedDate 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 13M 4M 5M 3M 13M 9M
costOfRevenue 5M 2M 2M 2M 5M 3M
grossProfit 8M 2M 3M 2M 8M 6M
grossProfitRatio 0.623 0.510 0.579 0.475 0.637 0.652
researchAndDevelopmentExpenses 678 000 1M 822 000 1M 1M 746 000
generalAndAdministrativeExpenses 949 000 2M 1M 1M 1M 1M
sellingAndMarketingExpenses 625 000 1M 2M 2M 2M 2M
sellingGeneralAndAdministrativeExpenses 2M 3M 3M 3M 3M 3M
otherExpenses 0 0 0 0 0 0
operatingExpenses 2M 4M 4M 5M 4M 4M
costAndExpenses 7M 6M 6M 6M 9M 7M
interestIncome 228 000 277 000 245 000 243 000 235 000 119 000
interestExpense 0 0 0 -243 000 235 000 1000.000
depreciationAndAmortization 60 000 277 000 83 000 73 000 235 000 119 000
ebitda 6M -2M -1M -3M 4M 2M
ebitdaratio 0.449 -0.415 -0.249 -0.861 0.336 0.253
operatingIncome 6M -2M -1M -3M 4M 2M
operatingIncomeRatio 0.444 -0.486 -0.249 -0.861 0.318 0.240
totalOtherIncomeExpensesNet 228 000 42 000 245 000 243 000 235 000 118 000
incomeBeforeTax 6M -2M -882 000 -3M 4M 2M
incomeBeforeTaxRatio 0.462 -0.404 -0.195 -0.790 0.336 0.253
incomeTaxExpense 2M -125 000 -502 000 -802 000 2M 450 000
netIncome 4M -1M -380 000 -2M 3M 2M
netIncomeRatio 0.335 -0.372 -0.084 -0.555 0.216 0.203
eps 0.260 -0.089 -0.023 -0.120 0.170 0.110
epsdiluted 0.260 -0.089 -0.023 -0.120 0.170 0.110
weightedAverageShsOut 16M 16M 16M 16M 16M 16M
weightedAverageShsOutDil 16M 16M 16M 16M 17M 17M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-15 2023-11-13 2023-08-11 2023-05-12 2023-03-23 2022-11-10
acceptedDate 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 23M 20M 20M 19M 26M 38M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 23M 20M 20M 19M 26M 38M
netReceivables 11M 7M 9M 13M 17M 7M
inventory 15M 13M 10M 6M 4M 2M
otherCurrentAssets 888 000 1M 8M 11M 7M 4M
totalCurrentAssets 50M 46M 47M 49M 54M 52M
propertyPlantEquipmentNet 1M 1M 1M 1M 1M 2M
goodwill 0 0 0 0 0 0
intangibleAssets 0 1000.000 1000.000 25 000 50 000 74 000
goodwillAndIntangibleAssets 0 1000.000 1000.000 25 000 50 000 74 000
longTermInvestments 0 24 000 24 000 0 0 0
taxAssets 2M 3M 3M 3M 2M 2M
otherNonCurrentAssets 803 999 281 000 350 000 443 000 24 000 36 000
totalNonCurrentAssets 4M 5M 5M 4M 3M 3M
otherAssets 1.000 0 0 0 0 0
totalAssets 54M 51M 52M 53M 57M 55M
accountPayables 3M 4M 4M 5M 6M 5M
shortTermDebt 187 000 183 000 181 000 192 000 190 000 220 000
taxPayables 37 000 0 0 0 890 000 233 000
deferredRevenue 657 000 708 000 692 000 671 000 693 000 1M
otherCurrentLiabilities 575 000 341 000 379 000 375 000 1M 535 000
totalCurrentLiabilities 4M 5M 5M 6M 8M 7M
longTermDebt 596 000 648 000 698 000 782 000 830 000 846 000
deferredRevenueNonCurrent 60 000 80 000 116 000 126 000 139 000 139 000
deferredTaxLiabilitiesNonCurrent 17 000 -80 000 0 0 0 0
otherNonCurrentLiabilities 0 80 000 0 0 0 -5M
totalNonCurrentLiabilities 673 000 728 000 814 000 908 000 969 000 985 000
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 596 000 831 000 879 000 974 000 1M 1M
totalLiabilities 5M 6M 6M 7M 9M 8M
preferredStock 0 1.000 0 0 0 0
commonStock 169 000 169 000 169 000 169 000 169 000 169 000
retainedEarnings 7M 3M 4M 4M 6M 3M
accumulatedOtherComprehensiveIncomeLoss 0.000 0.000 0 0 0 0
othertotalStockholdersEquity 42M 42M 42M 42M 42M 43M
totalStockholdersEquity 49M 45M 46M 46M 48M 47M
totalEquity 49M 45M 46M 46M 48M 47M
totalLiabilitiesAndStockholdersEquity 54M 51M 52M 53M 57M 55M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 54M 51M 52M 53M 57M 55M
totalInvestments 0 24 000 24 000 0 0 0
totalDebt 783 000 831 000 879 000 974 000 1M 1M
netDebt -22M -20M -19M -18M -25M -37M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol SRTS SRTS SRTS SRTS SRTS SRTS
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-15 2023-11-13 2023-08-11 2023-05-12 2023-03-23 2022-11-10
acceptedDate 2024-03-15 16:41:16 2023-11-13 17:22:22 2023-08-11 12:56:47 2023-05-12 15:29:37 2023-03-23 14:09:52 2022-11-10 14:22:42
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 4M -1M -380 000 -2M 3M 2M
depreciationAndAmortization 106 000 199 000 83 000 73 000 74 000 75 000
deferredIncomeTax 1M -125 000 -501 000 -802 000 -111 000 2M
stockBasedCompensation 52 000 67 000 66 000 143 000 50 000 40 000
changeInWorkingCapital -3M 2M 1M -4M -14M -551 000
accountsReceivables -4M 2M 4M 5M -10M 3M
inventory 1M -3M -4M -3M -1M -709 000
accountsPayables -1M 58 000 -987 000 -593 000 638 000 167 000
otherWorkingCapital 748 000 3M 3M -5M -3M -3M
otherNonCashItems 285 001 2000.000 118 000 163 000 812 000 188 000
netCashProvidedByOperatingActivities 3M 442 000 742 000 -6M -10M 4M
investmentsInPropertyPlantAndEquipment 0 -11 000 -29 000 -189 000 -10000.000 -60 000
acquisitionsNet 0 42 000 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0
otherInvestingActivites 0 42 000 0 0 0 0
netCashUsedForInvestingActivites 0 31 000 -29 000 -189 000 -10000.000 -60 000
debtRepayment 0 0 0 0 0 0
commonStockIssued 0 0 0 0 0 0
commonStockRepurchased -7000.000 -27 000 0 0 -2M 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites -7000.000 -12 000 0 6000.000 60 000 211 000
netCashUsedProvidedByFinancingActivities -7000.000 -39 000 0 6000.000 -2M 211 000
effectOfForexChangesOnCash 0 0 0 0 0 0
netChangeInCash 3M 434 000 713 000 -6M -12M 4M
cashAtEndOfPeriod 23M 20M 20M 19M 26M 38M
cashAtBeginningOfPeriod 20M 20M 19M 26M 38M 34M
operatingCashFlow 3M 442 000 742 000 -6M -10M 4M
capitalExpenditure 0 -11 000 -29 000 -189 000 -10000.000 -60 000
freeCashFlow 3M 431 000 713 000 -6M -10M 4M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-08 ET (fiscal 2023 q4)
2023 q3
2023-11-09 ET (fiscal 2023 q3)
2023 q2
2023-08-06 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-09 ET (fiscal 2022 q4)
2022 q3
2022-11-06 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-08 21:05 ET
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-08 13:00 ET
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities
2024-02-06 13:00 ET
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
2024-02-01 13:00 ET
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
2024-01-30 13:00 ET
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024
2024-01-23 13:00 ET
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
2023-11-09 21:05 ET
Sensus Healthcare Reports Third Quarter 2023 Financial Results
2023-11-02 12:00 ET
Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023
2023-10-09 12:00 ET
Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
2023-09-28 12:30 ET
Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital
2023-09-26 12:00 ET
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego
2023-08-08 12:30 ET
Sensus Healthcare Announces New $3 Million Share Repurchase Program
2023-08-03 20:05 ET
Sensus Healthcare Reports Second Quarter 2023 Financial Results
2023-07-26 12:30 ET
Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
2023-07-25 12:30 ET
Sensus Healthcare Completes Installation of its First SRT System in Ireland
2023-07-06 20:05 ET
Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
2023-06-15 12:00 ET
Sensus Healthcare to Participate in the Maxim Group Virtual Healthcare Conference Hosted by M-Vest
2023-05-17 12:00 ET
Sensus Healthcare's SRT Treatment Shows Promise in Treating Cutaneous Mast Cell Tumors Among Pet Patients
2023-05-03 20:05 ET
Sensus Healthcare Reports First Quarter 2023 Financial Results
2023-04-25 20:05 ET
Sensus Healthcare to Host First Quarter 2023 Financial Results and Business Update Conference Call on Wednesday, May 3, 2023
2023-03-16 20:09 ET
Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19
2023-02-09 21:05 ET
Sensus Healthcare Fourth Quarter 2022 Financial Results Include Quarterly Revenues of $13.1 Million
2023-02-01 21:05 ET
Sensus Healthcare to Host Fourth Quarter 2022 Financial Results and Business Update Conference Call on February 9, 2023
2023-01-09 13:00 ET
Sensus Healthcare Announces Senior Management Appointments and Promotions
2023-01-05 21:05 ET
Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues
2022-11-03 20:05 ET
Sensus Healthcare Reports Third Quarter 2022 Financial Results
2022-10-27 12:00 ET
Sensus Healthcare to Host Third Quarter 2022 Financial Results and Business Update Conference Call on November 3, 2022
2022-10-20 15:56 ET
Sensus Healthcare Introduces Silk™ Laser Hair Removal System
2022-09-09 12:00 ET
Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference
2022-09-07 12:00 ET
Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board
2022-08-09 20:25 ET
Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities
2022-08-04 20:05 ET
Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%
2022-07-27 12:00 ET
Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum
2022-07-26 12:00 ET
Sensus Healthcare to Host Second Quarter 2022 Financial Results and Business Update Conference Call on August 4, 2022
2022-07-20 12:00 ET
Colorado State University College of Veterinary Medicine and Biomedical Sciences Acquires Second SRT System from Sensus Healthcare
2022-05-18 20:05 ET
Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
2022-05-05 20:05 ET
Sensus Healthcare First Quarter 2022 Financial Results Feature Revenue Growth of 237%
2022-04-21 12:00 ET
Sensus Healthcare to Host First Quarter 2022 Financial Results and Business Update Conference Call on May 5, 2022
2022-03-24 12:00 ET
Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
2022-03-09 21:05 ET
Sensus Healthcare to Present at Two Investment Conferences in March
2022-03-09 13:00 ET
Sensus Healthcare Announces Share Repurchase Program
2022-03-02 13:00 ET
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
2022-02-10 21:05 ET
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
2022-01-31 21:05 ET
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
2022-01-26 13:30 ET
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
2022-01-06 18:07 ET
Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference
2022-01-05 13:00 ET
Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference
2021-12-01 13:30 ET
Sensus Healthcare Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia for its TransDermal Infusion System
2021-11-04 20:02 ET
Sensus Healthcare Reports Third Quarter 2021 Financial Results
2021-10-20 12:30 ET
Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021
2021-10-15 12:30 ET
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
2021-10-12 12:30 ET
Chinese Health Authority Renews License for Sensus Healthcare’s SRT-100™ for Five More Years
2021-10-07 12:30 ET
Sensus Healthcare Announces Presentations, Demonstrations and Exhibit Booth at the 2021 Fall Clinical Conference in Las Vegas
2021-09-08 13:00 ET
Sensus Healthcare to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
2021-08-05 20:05 ET
Sensus Healthcare Reports Second Quarter 2021 Financial Results
2021-07-29 12:00 ET
Sensus Healthcare to Host Second Quarter 2021 Financial Results and Business Update Conference Call on August 5, 2021
2021-07-22 12:00 ET
Sensus Healthcare Announces Participation in A.G.P.’s Virtual MedTech Summer Conference on July 29, 2021
2021-05-06 20:05 ET
Sensus Healthcare Reports First Quarter 2021 Financial Results
2021-04-29 20:00 ET
Sensus Healthcare to Host First Quarter 2021 Financial Results and Business Update Conference Call on May 6, 2021

SEC forms

Show financial reports only

SEC form 10
2024-03-15 00:00 ET
Sensus Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Sensus Healthcare published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
Sensus Healthcare reported for 2023 q4
SEC form 10
2023-11-13 00:00 ET
Sensus Healthcare published news for 2023 q3
SEC form 8
2023-11-09 16:07 ET
Sensus Healthcare reported for 2023 q3
SEC form 10
2023-08-11 00:00 ET
Sensus Healthcare published news for 2023 q2
SEC form 6
2023-08-03 16:05 ET
Sensus Healthcare reported for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Sensus Healthcare published news for 2023 q2
SEC form 6
2023-06-06 16:01 ET
Sensus Healthcare published news for 2023 q1
SEC form 10
2023-05-12 00:00 ET
Sensus Healthcare published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
Sensus Healthcare published news for 2023 q1
SEC form 10
2023-03-23 14:09 ET
Sensus Healthcare reported for 2022 q4
SEC form 10
2023-03-23 00:00 ET
Sensus Healthcare reported for 2022 q4
SEC form 6
2023-02-09 16:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 8
2023-02-09 00:00 ET
Sensus Healthcare reported for 2022 q4
SEC form 6
2023-01-09 17:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Sensus Healthcare published news for 2022 q4
SEC form 10
2022-11-10 14:22 ET
Sensus Healthcare reported for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Sensus Healthcare reported for 2022 q3
SEC form 6
2022-11-03 16:13 ET
Sensus Healthcare published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Sensus Healthcare reported for 2022 q3
SEC form 10
2022-08-12 13:03 ET
Sensus Healthcare reported for 2022 q2
SEC form 10
2022-08-12 00:00 ET
Sensus Healthcare reported for 2022 q2
SEC form 6
2022-08-04 16:12 ET
Sensus Healthcare published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Sensus Healthcare reported for 2022 q2
SEC form 6
2022-06-09 09:00 ET
Sensus Healthcare published news for 2022 q1
SEC form 10
2022-05-12 16:23 ET
Sensus Healthcare reported for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Sensus Healthcare reported for 2022 q1
SEC form 6
2022-05-05 16:12 ET
Sensus Healthcare published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Sensus Healthcare reported for 2022 q1
SEC form 6
2022-04-29 09:54 ET
Sensus Healthcare published news for 2022 q1
SEC form 10
2022-03-25 16:03 ET
Sensus Healthcare published news for 2021 q4
SEC form 10
2022-03-25 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-03-09 11:33 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-03-03 13:35 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-02-10 16:45 ET
Sensus Healthcare published news for 2021 q4
SEC form 8
2022-02-10 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-01-31 16:10 ET
Sensus Healthcare published news for 2021 q4
SEC form 6
2022-01-05 14:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 8
2022-01-05 00:00 ET
Sensus Healthcare published news for 2021 q4
SEC form 10
2021-11-10 14:23 ET
Sensus Healthcare published news for 2021 q3
SEC form 10
2021-11-10 00:00 ET
Sensus Healthcare published news for 2021 q3
SEC form 6
2021-11-04 16:18 ET
Sensus Healthcare published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Sensus Healthcare published news for 2021 q3
SEC form 10
2021-08-13 10:09 ET
Sensus Healthcare published news for 2021 q2
SEC form 10
2021-08-13 00:00 ET
Sensus Healthcare published news for 2021 q2
SEC form 6
2021-08-05 16:17 ET
Sensus Healthcare published news for 2021 q2
SEC form 6
2021-06-04 16:00 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-05-14 12:19 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-05-14 00:00 ET
Sensus Healthcare published news for 2021 q1
SEC form 6
2021-05-06 16:05 ET
Sensus Healthcare published news for 2021 q1
SEC form 6
2021-04-30 12:42 ET
Sensus Healthcare published news for 2021 q1
SEC form 10
2021-03-05 12:58 ET
Sensus Healthcare published news for 2020 q4
SEC form 6
2021-02-25 16:11 ET
Sensus Healthcare published news for 2020 q4
SEC form 6
2021-01-11 11:02 ET
Sensus Healthcare published news for 2020 q4
SEC form 10
2020-11-10 13:44 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-11-05 17:09 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-11-05 16:14 ET
Sensus Healthcare published news for 2020 q3
SEC form 6
2020-10-01 17:32 ET
Sensus Healthcare published news for 2020 q3